Your pancreas is a gland that makes enzymes to digest your food and hormones to regulate your blood sugar levels. Your pancreas is shaped like a comma and located deep in your belly, between your ...

Pancreatic cancer is a devastating disease and once someone in your family ... rates of the disease have soared by 200 per cent among women under the age of 25 in the same period.

Exocrine pancreatic insufficiency (EPI ... like cystic fibrosis, Crohn’s disease, celiac disease, and diabetes, have additional special dietary requirements. An EPI diet prioritizes balanced ...

They characteristically contain ovarian-like stroma and almost exclusively affect women in ... factors for pancreatic cancer. Such factors include a family history of the disease and specific ...

People with exocrine pancreatic insufficiency (EPI) have higher rates of cancer, heart disease, and malnutrition, which can affect life expectancy. Studies show having complications of EPI ...

Using genome engineered stem cells, we are generating stem cell derived pancreatic islets to create in vitro and in vivo disease models of diabetes. By integrating single-cell omic data and ...

The management of alcoholic pancreatitis is mostly reactive; little is done to prevent disease progression. It is time for physicians to pay attention to the root cause of the condition—that is ...

In a Q&A, Yale pancreatic disease expert James Farrell discusses his work to improve pancreatic cyst treatment and the assessment of cancer risk. Carolyn Mazure, a national leader in women’s health ...

Background and Aim: Intraductal papillary mucinous tumor (IPMT) of the pancreas can be divided into three clinically distinct subtypes: main duct type, branch duct type and mixed type. Although it ...

People are invited to use the checker and will be asked three questions covering their family history of pancreatic cancer, other genetic conditions associated with the disease and pancreatitis.

The five-year survival rate for stage 1 pancreatic cancer is more than 83%, but that drops to just 3% for patients with stage 4 disease—which is when most patients are currently diagnosed.